# data[].attributes.headline
Dr. Raetasha Dabney Explains How Lung Cancer Recurs

# data[].attributes.subject
Dr. Raetasha Dabney Explains How Lung Cancer Recurs

# data[].attributes.body
Recurrent lung cancer is common and can be defined according to the location of the recurrence.

# data[].attributes.attachment_link.readable_text
Understanding Lung Cancer Recurrence

Decatur, TX - May 14, 2020 - In some patients, lung cancer can come back after treatment. The disease is likely to recur within five years after diagnosis. Recurrent lung cancer is common and can be defined according to the location of the recurrence. There are three forms of lung cancer recurrence, which are treated based on the size and location of the cancer.

"After treatment, tiny cancer cells can remain in the body. Over time, the cells will start growing and multiplying to form cancer again," explained Dr. Tower. "The chances that your lung cancer will recur depends on your type of lung cancer, the stage at which it was diagnosed, and the treatment options you received for the original disease. Your lung cancer may return in the lungs or other different parts of your body."

The types of lung cancer recurrence include;

Local recurrence - A local recurrence is when lung cancer returns to the lung near the location of the original tumor.

Regional recurrence - This is when cancer comes back in the lymph nodes surrounding the original tumor.

Distant recurrence - In distant recurrence, lung cancer will recur in different sites such as the brain, liver, bones, and adrenal glands.

In recurrent lung cancer, you will experience symptoms based on the location of your recurrence. For regional recurrence, you may cough up blood, experience shortness of breath and pneumonia. Distant recurrence presents symptoms such as dizziness, loss of coordination, and double vision. If you have a local recurrence, you'll experience abdominal pain and jaundice.

"The common causes of lung cancer recurrence are cells that spread to distant sites through lymphatic channels or the bloodstream," continued Dr. Tower. "These cancerous cells may be too small to be detected and will regrow into cancer. Chemotherapy treatment may also not eliminate all the cancer cells. The surviving cells will also begin to grow over time and cause cancer. Always talk to your doctor if you experience symptoms."

# data[].attributes.attachment_link.title
Dr. Raetasha Dabney Explains How Lung Cancer Recurs

# data[].attributes.attachment_link.description
Understanding Lung Cancer Recurrence Decatur, TX - May 14, 2020 - In some patients, lung cancer can come back after treatment. The disease is likely to recur within five years after diagnosis. Recurrent lung cancer is common and can be defined according to the location of the recurrence.

# data[].attributes.headline
Guidelines for Patients to Access Cancer Care during Covid-19

# data[].attributes.subject
Guidelines for Patients to Access Cancer Care during Covid-19

# data[].attributes.body
The Federal guidelines have allowed cancer patients to access care even with the ongoing coronavirus epidemic. Since the outbreak of Covid-19, cancer care teams and their patients have experienced difficulty in making choices about administering treatments.

# data[].attributes.attachment_link.readable_text
The Federal guidelines have allowed cancer patients to access care even with the ongoing coronavirus epidemic. Since the outbreak of Covid-19, cancer care teams and their patients have experienced difficulty in making choices about administering treatments, screening, and diagnostic care.

The guidelines provided earlier advised some care centers to postpone non-essential and elective procedures to allow medical professionals to focus on emergency and Covid-19 patients. The hospitals will remain open and provide treatments critical to patients and others who have no access to care from their local healthcare centers. Other cancer procedures, like cancer screening, will be rescheduled or postponed.

Patients have been faced with uncertainty following the directive since their scheduled procedures have had to be delayed.

New guidelines from the U.S. Center for Medicare and Medicaid Services are a welcome relief for cancer patients in some regions. Hospitals have been advised to ease some of the restrictions and allow patients to access non-emergency and non-Covid-19 procedures and care. These guidelines are intended to work hand in hand with other steps taken by the government to enable a phased-in reopening of certain businesses while ensuring a decrease in new COVID-19 cases.

Now cancer patients can continue to receive care when they need it, including telehealth services. Hospitals and medical staff will continue to provide clinical and surgical procedures and administer preventive services when necessary.

Hospitals will need to establish non-Covid care zones to screen their staff and patients regularly. They must have adequate personal protective equipment for their patients and medical staff. The social distancing guidelines should be enacted and enforced and have quarantine areas for those who test positive for COVID-19.

All public spaces, hospital equipment, and patient rooms should be thoroughly cleaned and disinfected. The guidelines also direct that hospitals should have an adequate supply of medication, equipment, and supplies.

These new protocols will help prevent infection and spread of Coronavirus in hospitals. By observing them, hospitals will ensure the safety of their patients and staff while continuing to offer adequate cancer care to those who need it.

# data[].attributes.attachment_link.title
New Guidelines for Patients to Access Cancer Care during Covid-19

# data[].attributes.attachment_link.description
The Federal guidelines have allowed cancer patients to access care even with the ongoing coronavirus epidemic. Since the outbreak of Covid-19, cancer care teams and their patients have experienced difficulty in making choices about administering treatments, screening, and diagnostic care.

# data[].attributes.headline
Metastatic Lung Cancer Patients and Use of Immunotherapy

# data[].attributes.subject
Metastatic Lung Cancer Patients and Use of Immunotherapy

# data[].attributes.body
Metastatic lung cancer patients should continue with immunotherapy for up to 2 years if they are responsive and are not experiencing excessive toxicity or disease progression.

# data[].attributes.attachment_link.readable_text
Metastatic lung cancer patients should continue with immunotherapy for up to 2 years if they are responsive and are not experiencing excessive toxicity or disease progression.

Initially, stage III lung cancer patients usually undergo immunotherapy for one year as established in one clinical trial. The trial results showed that durvalumab (imfinzi) could prolong overall survival and progression-free survival in stage III unresectable non-small cell lung cancer compared to placebo in patients who didn't have disease progression after concurrent chemoradiotherapy.

However, there are rules for those patients undergoing immunotherapy for metastatic disease. If they experience excessive toxicity or progression of the disease, they should stop taking the drugs. But if they have a response, they can continue with treatment for up to 2 years. At this time, the doctors will have to talk to the patient to explain the downsides and upsides of stopping or continuing with therapy.

Based on data from another trial, about two-thirds of patients who took pembrolizumab (Keytruda) for two years remained responsive to treatment even after it was stopped. After 43 months of follow-up, it was observed that pembrolizumab continued to prolong the overall survival versus docetaxel in patients who were previously treated with PD-L1-expressing advanced non-small cell lung cancer with manageable long-term safety. Most of the patients who completed all the 35 cycles of pembrolizumab during the trial had a durable response to treatment.

Treatment is often stopped when patients experience chronic adverse effects, such as arthralgias or fatigue. Patients start experiencing mild effects in the first few months, but later they'd have severe experiences, including transaminitis or pneumonitis. Endocrinopathies (thyroid) is also common but can be managed.

Scientists are working to determine which patient can benefit from these approaches. They are looking for clinical characteristics or biomarkers that could help identify patients who qualify for chemotherapy alone. That's why biomarker research is ongoing to help them get the algorithms that'll guide their decision making.

# data[].attributes.attachment_link.title
When Metastatic Lung Cancer Patients Should Stop Using Immunotherapy

# data[].attributes.attachment_link.description
Metastatic lung cancer patients should continue with immunotherapy for up to 2 years if they are responsive and are not experiencing excessive toxicity or disease progression. Initially, stage III lung cancer patients usually undergo immunotherapy for one year as established in one clinical trial.

# data[].attributes.headline
Does Carcinogens Cause the Development of Breast Cancer?

# data[].attributes.subject
Does Carcinogens Cause the Development of Breast Cancer?

# data[].attributes.body
People get exposed to ionizing radiation from radiation treatment, CT scans, and X-rays, among many other sources. A lot of studies have been carried out to determine the effects of radiation on breast cancer.

# data[].attributes.attachment_link.readable_text
Scientists have created a map with details on how environmental chemicals can trigger breast cancer. They used the ionizing radiation model to identify the cell mechanisms that cause breast cancer when disrupted. Since these findings can be generalized to various environmental carcinogens, they could help find out the chemicals responsible for the high breast cancer risk.

Although exposure to toxic chemicals contributes to breast cancer development, its effects on the breast are not well established. The gap in testing may mean that potential breast carcinogens are being used in consumer products.

Breast cancer incidence rates are the highest in Europe and North America, and only 5-10% of the breast cancers are from high risk inherited mutations like BRCA1 and BRCA2. Scientists are working to understand the role that environmental factors play in the development of the disease and ways to minimize incidence rates and prevent future disease development.

People get exposed to ionizing radiation from radiation treatment, CT scans, and X-rays, among many other sources. A lot of studies have been carried out to determine the effects of radiation on breast cancer. It's from the reviews of these studies that researchers sought to identify the sequence of biological changes occurring in breast tissue and cells from the time a patient is exposed to the time of tumor formation. Their findings revealed multiple interconnected pathways that indicated that ionizing radiation causes breast cancer.

According to traditional models, ionizing radiation causes breast cancer through DNA damage. But the new model shows that both radiation and DNA damage increase the production of reactive oxygen and nitrogen species of molecules. The molecules cause havoc within cells, altering their DNA, disrupting critical biological functions, and causing inflammation.

This study is aimed at gathering mechanistic evidence that identifies potential carcinogens triggering breast cancer.

The team also discovered that reproductive hormones such as progesterone and estrogen also influence the biological changes that cause breast cancer by stimulating cell proliferation within the breast. This causes the chemicals that encourage cell proliferation to make the breast more susceptible to tumors, especially during puberty or pregnancy.

The research team has identified test regulators to help find the chemicals that are potential breast cancer carcinogens and discourage their use in products.

# data[].attributes.attachment_link.title
How Carcinogens Cause the Development of Breast Cancer

# data[].attributes.attachment_link.description
Scientists have created a map with details on how environmental chemicals can trigger breast cancer. They used the ionizing radiation model to identify the cell mechanisms that cause breast cancer when disrupted. Since these findings can be generalized to various environmental carcinogens, they could help find out the chemicals responsible for the high breast cancer risk.

# data[].attributes.headline
How Exercise Can Help Protect Against COVID-19 and Prostate Cancer

# data[].attributes.subject
How Exercise Can Help Protect Against COVID-19 and Prostate Cancer

# data[].attributes.body
Coronavirus became a pandemic quickly, causing many deaths due to a shortage of medical resources such as ventilators for patients and personal protective equipment for care providers in hospitals around the world.

# data[].attributes.attachment_link.readable_text
Coronavirus became a pandemic quickly, causing many deaths due to a shortage of medical resources such as ventilators for patients and personal protective equipment for care providers in hospitals around the world.

COVID-19 can be lethal to people with known vulnerabilities and severe complications. If you have a condition known as Acute Respiratory Distress Syndrome (ARDS), you're at risk of contracting COVID-19, pneumonia, and blood infection, which can lead to death.

The condition damages the normal lung mechanisms that help to oxygenate circulating blood. It compromises the membrane that protects small blood vessels from leaking fluid into air sacs that oxygenate the blood. When the heart pumps depleted blood to the body, cells in tissues will die for lack of oxygen and suffocate all the body parts. Patients with this condition are put on ventilators to help raise their oxygen levels.

A new study suggests that regular aerobic exercise can help to prevent patients with coronavirus from developing adverse complications. Researchers based their investigation on a powerful antioxidant known as extracellular superoxide dismutase (EcSOD), which can neutralize free radicals in the body.

Free radicals are known to cause oxidation in the body by stealing electrons from necessary proteins, DNA, and cell membranes. But when neutralized by antioxidants, the body tissues will remain functional.

Endurance exercise can promote EcSOD expression in skeletal muscles and produce natural antioxidant which protects the body from free radicals that damage lung tissues. Enhanced expression of EcSOD from all the tissues and other body organs can reduce the severity and risk of ARDS due to COVID-19.

Experts note that 30 minutes of daily aerobics can help you reduce the severity of ARDS, maintain cellular longevity, and heart health. In earlier studies, exercise was found to have protective anti-inflammatory effects against cancer.

A new international clinical study is being launched to determine how intense exercise can help increase survival in men with metastatic castrate-resistant prostate cancer. The study is built on previous evidence proving that physical activity directly impacts cancer progressions and helps patients to tolerate treatments and minimize the side effects of chemotherapy.

The underlying theory is for exercise to act as a drug that alters gene expression and other biochemistry to ensure overall survival is extended. Overall, the researchers propose that exercise has a therapeutic potential to protect and boost mental, physical, psychological, and emotional wellness.

# data[].attributes.attachment_link.title
Exercise Can Help Protect Against COVID-19 and Prostate Cancer

# data[].attributes.attachment_link.description
Coronavirus became a pandemic quickly, causing many deaths due to a shortage of medical resources such as ventilators for patients and personal protective equipment for care providers in hospitals around the world. COVID-19 can be lethal to people with known vulnerabilities and severe complications.

# data[].attributes.headline
Dr. Amelia Tower highlights the various benefits of ultrasound imaging in cancer

# data[].attributes.subject
Dr. Amelia Tower highlights the various benefits of ultrasound imaging in cancer

# data[].attributes.body
Ultrasound can complement other screening tests to ensure accurate outcomes. It helps to guide surgeons during breast biopsies to make sure accurate samples are taken.

# data[].attributes.attachment_link.readable_text
Decatur, TX - Mar 14, 2020 - A breast ultrasound uses sound waves to image the breast. It is a non-invasive imaging test used as a follow-up after finding an abnormality in the breast through mammography, clinical breast exam, or breast MRI. A doctor may discover a lump in the breast and will conduct an ultrasound to determine if the lump is solid (cancerous) or filled with fluid (benign cyst). An ultrasound can also help to assess nipple discharge, evaluate breast inflammation, monitor breast implants, and much more.

"A breast ultrasound procedure takes about 15 to 30 minutes, and it offers many benefits to the patient," explained Dr. Tower. "The ultrasound can complement other screening tests to ensure accurate outcomes. It helps to guide surgeons during breast biopsies to make sure accurate samples are taken. It also guides the needle during the aspiration of a cyst when removing fluids."

Here are some of the benefits of breast ultrasounds;

They produce high contrast images that help distinguish cysts from solid lumps that may cause cancer. They can also locate lumps that you cannot feel (nonpalpable masses).

Ultrasounds are painless procedures.

Ultrasounds help doctors to distinguish lymph nodes from malignant tumors.

They can detect any changes in dense breasts. When used alongside mammograms, ultrasounds help to increase the detection of early breast cancer in patients with dense breast tissue.

Ultrasounds do not use radiation. This makes them ideal tools for pregnant or breastfeeding women or those with breast implants and those aged 30 years and below.

An ultrasound is affordable compared to other imaging techniques such as magnetic resonance imaging and computed tomography.

"Before having an ultrasound, you should talk to your doctor to understand the details of the procedure and what it means in your case," continued Dr. Tower. "However, regardless of the purpose of the ultrasound, you should know that the procedure is the same. It is a painless procedure with no after-effects to the patient. After the test, you can resume your normal activities as soon as possible."

# data[].attributes.attachment_link.title
Dr. Amelia Tower Highlights the Benefits Of Ultrasound Imaging In Cancer

# data[].attributes.attachment_link.description
Decatur, TX - Mar 14, 2020 - A breast ultrasound uses sound waves to image the breast. It is a non-invasive imaging test used as a follow-up after finding an abnormality in the breast through mammography, clinical breast exam, or breast MRI.

# data[].attributes.headline
Surgery is the Best Option for Early-Stage Colon Cancer

# data[].attributes.subject
Surgery is the Best Option for Early-Stage Colon Cancer

# data[].attributes.body
The large intestine (colorectum) is a crucial component of the digestive system. Cancer found in any part of the colon can spread to the lungs, liver, bones, and other organs in the body.

# data[].attributes.attachment_link.readable_text
The large intestine (colorectum) is a crucial component of the digestive system. Cancer found in any part of the colon can spread to the lungs, liver, bones, and other organs in the body.

Individuals with personal or family history of colon cancer may start experiencing symptoms at age 25-35. Therefore, it is recommended to go for genetic testing after consulting with their oncologist.

Known risk factors for colorectal cancer include inflammatory bowel disease, excessive consumption of alcohol, tobacco, and red meat, low-fiber diet, age, and family history of the disease.

In its early stages, colon cancer can be cured by surgery. The whole tumor can be removed or a part of the rectum or colon that has cancer. The surgical procedure involves making a few small cuts in the belly (laparoscopy).

A patient undergoing colon surgery is often put on a special diet before the operation. They may also use enemas and laxative drinks to cleanse the colon.

If the tumor is small, the doctor will perform minimally invasive surgery to remove small polyps. This can be done during a colonoscopy. Larger polyps can also be removed during colonoscopy in a procedure known as endoscopic mucosal resection. A small part of the colon's inner lining will also be chucked out.

As it advances to Stage III, the patient will have to undergo surgery and chemotherapy for about six months. Advanced stage colorectal cancer can be treated with targeted therapy and chemotherapy.

Targeted therapies have revolutionized the treatment of stage IV colorectal cancer. This has greatly improved patients' overall health and recovery time. Many have managed to avoid unnecessary drug treatments and save a lot on medical expenses. Doctors use the KRAs and NRAS biomarker tests on stage IV metastatic colorectal cancer patients to predict the most beneficial treatment for them.

Colorectal cancer is curable even in about 20% of stage IV cases with liver metastasis.

# data[].attributes.attachment_link.title
Surgery is the Best Option for Early-Stage Colon Cancer

# data[].attributes.attachment_link.description
The large intestine (colorectum) is a crucial component of the digestive system. Cancer found in any part of the colon can spread to the lungs, liver, bones, and other organs in the body. Individuals with personal or family history of colon cancer may start experiencing symptoms at age 25-35.

# data[].attributes.body
Annual PSA testing can be carried out after consultation and agreement between doctor and patient. This can help you decide whether mpMRI can help find out what’s causing your PSA levels to rise.

# data[].attributes.attachment_link.readable_text
A prostate-specific antigen (PSA) test is the most commonly used tool for screening for prostate cancer. The simple blood test helps to measure the level of PSA in the blood. PSA assists in prostate cancer diagnosis, recurrence, and tracking of treatments like chemotherapy, hormone therapy, radiation, and surgery.

When a patient is treated, their PSA level will significantly drop. If the PSA level rises after treatment, the patient will have what is called biochemical recurrence, which requires additional tests and treatment.

Some years back, doctors had discontinued the annual PSA screening for men who are not at high risk for prostate cancer. This was due to the US Preventive Services Task Force downgrading of the procedure, citing that its harms outweigh patient benefits.

Later on, when the rate of newly diagnosed cases of high-risk prostate cancer began to rise, the USPSTF allowed for PSA screening to reduce deaths from prostate cancer. This goes to show that it recognizes the potential benefit of PSA screening, even if in small margins. It, therefore, recommends that men should discuss their benefits and risks with their doctors and decide whether to get tested or not.

However, many organizations recommend that men should be educated about prostate cancer to help them understand their options for early detection. They should also have access to the latest screening tests. A PSA test score can help decide how to determine the diagnosis or treatment for prostate cancer.

Due to advanced preventive measures, early detection, and treatment breakthroughs, there has been a drop in prostate cancer death rates. More positive outcomes will be realized if men take the initiative to get screened annually. This could help to detect the disease early, get the right treatment, and save many lives.

PSA screening is still recommended and can be used with other procedures such as multiparametric MRI (mpMRI) before a biopsy.

Annual PSA testing can be carried out after consultation and agreement between doctor and patient. This can help you decide whether mpMRI can help find out what's causing your PSA levels to rise. It's better to take the test than ignore and put your prostate health at risk.

# data[].attributes.attachment_link.description
A prostate-specific antigen (PSA) test is the most commonly used tool for screening for prostate cancer. The simple blood test helps to measure the level of PSA in the blood. PSA assists in prostate cancer diagnosis, recurrence, and tracking of treatments like chemotherapy, hormone therapy, radiation, and surgery.

# data[].attributes.headline
When to Get a Second Opinion on Breast Cancer Treatment in Texas

# data[].attributes.subject
When to Get a Second Opinion on Breast Cancer Treatment in Texas

# data[].attributes.body
A second opinion can alter your earlier diagnostic details and suggest different treatment options, or even change the entire course of your treatment.

# data[].attributes.attachment_link.readable_text
A patient can get a second opinion any time during their cancer care process. The most appropriate time, though, is to seek one before you commence your treatment. A second opinion can alter your earlier diagnostic details and suggest different treatment options, or even change the entire course of your treatment.

You can take a few weeks to get another opinion, so talk to your doctor to let them know that it'll take some time before starting your treatment. In any case, the delay will not interfere with your treatment.

Here are some critical points that will guide you as you seek a second opinion.

Since every individual's situation is different, you, your cancer care team, and loved ones, can work together in order to decide the best option for your case.

Your doctor will authorize a series of tests after receiving the pathology report to create a profile on the activity of your breast cancer. Combined with lab test results, the pathology report will provide all the information needed to develop a tailored treatment plan that will work best for your diagnosis. One mistake on the part of the pathologist or lab results can alter your treatment plan.

Mammograms, MRIs, and ultrasounds help to determine the extent of breast cancer before the patient undergoes surgery. Having another radiologist check your images and offer their opinion on the results, or getting a second opinion from the breast surgeon on the type of surgery to have can also help. Another plastic surgeon can also help you decide the best breast reconstruction procedure from the many options available.

In general, all the information regarding your diagnosis and treatment, along with your personal needs and preferences, will help determine the appropriate treatment for your unique situation. It is, therefore, wise to get a second opinion to help you make the right decision.

Getting another expert to review your cancer details will offer you additional advice or give you the reassurance and confidence to continue with treatment.

# data[].attributes.attachment_link.title
When to Get a Second Opinion on Breast Cancer Treatment in Texas

# data[].attributes.attachment_link.description
A patient can get a second opinion any time during their cancer care process. The most appropriate time, though, is to seek one before you commence your treatment. A second opinion can alter your earlier diagnostic details and suggest different treatment options, or even change the entire course of your treatment.

# data[].attributes.headline
Is Lung Cancer Treatable if Detected Early?

# data[].attributes.subject
Is Lung Cancer Treatable if Detected Early?

# data[].attributes.body
Lung cancer leads in all cancer deaths across the world. The reason it is deadly is that the disease is often diagnosed late after it has spread beyond the lungs.

# data[].attributes.attachment_link.readable_text
Lung cancer leads in all cancer deaths across the world. The reason it is deadly is that the disease is often diagnosed late after it has spread beyond the lungs. Recent studies have shown that CT scans can help identify the disease early in high-risk patients. Early diagnosis and treatment can save many lives.

The signs and symptoms for lung cancer include persistent coughs, shortness of breath, chest pain, coughing up blood, and wheezing.

Non-small cell lung cancer is the most common among all lung cancers. It grows from the lung cells and controls the normal functioning of the lung. When the tumors grow and divide, they spread to the brain and bones.

Both women and men are at risk for lung disease. Smoking is the primary risk factor for lung cancer. Only a small percentage of lung cancer patients are non-smokers. Other causal factors include exposure to asbestos and radon gas and family history of the disease.

Screening is the best way to prevent lung cancer. A study found that low-dose CT scans can improve the odds for patients. The scans are safe and recommended for people aged 50 and above with a 30 pack a year smoking history. Regular CT scans can help in early detection and allow the patient to undergo minimal surgery.

Catching lung cancer early will make it possible for cure by surgical removal. A small surgery known as video-assisted thoracic surgery (VATS) can be performed. The surgeon will take out a lobe section of the lung through three little incisions in the chest. The procedure is safe and will preserve most of the healthy lung. Larger tumors can be treated by surgically removing the whole lung.

Lung cancer screening is the only way to find the disease early and cure it. You should, therefore, talk to your doctor to find the best screening method for you.

# data[].attributes.attachment_link.title
Is Lung Cancer Treatable if Detected Early? | Cancer Center Texas

# data[].attributes.attachment_link.description
Lung cancer leads in all cancer deaths across the world. The reason it is deadly is that the disease is often diagnosed late after it has spread beyond the lungs. Recent studies have shown that CT scans can help identify the disease early in high-risk patients. Early diagnosis and treatment can save many lives.

# data[].attributes.headline
Various complications experienced by lung cancer patients explained by Dr. Juan Godinez

# data[].attributes.subject
Various complications experienced by lung cancer patients explained by Dr. Juan Godinez

# data[].attributes.body
According to Dr. Godinez Lung cancer is often diagnosed late and may not show complications or symptoms until in later stages.

# data[].attributes.attachment_link.readable_text
Decatur, TX - February 13, 2020 - When detected early, lung cancer can be treated. A patient should understand the symptoms in order to get diagnosed early. Lung cancer may cause complications to the lungs and other body parts, and the complications may occur over time as the disease develops and advances.

" Lung cancer is often diagnosed late and may not show complications or symptoms until in later stages," says Dr. Godinez. "The outlook of the disease will depend on various factors, including how far the cancer has spread."

Here are the common complications from lung cancer:

Heart complications - Lung cancer can cause complications to the heart when it occurs near the major blood vessels. This makes the fluid press against the heart leading to general fatigue, headaches and dizziness, problems with vision and swelling in the face, chest, and neck.

Lung complications - Complications in the lungs due to lung cancer can cause problems such as bronchitis, pneumonia, back, shoulder and chest pain, coughing up phlegm or mucus, shortness of breath, coughing up blood and hoarse voice.

Pleural effusion - Pleural effusion occurs when fluid builds up in the membrane covering the lungs. When the fluid presses on the lungs, the patient will become breathless.

Neuropathy - Neuropathy causes tingling and numbness in the feet and hands because of damaged nerve tissue. It occurs when tumors grow near the nerves found in the shoulders or arms. The tumors will compress the nerves and cause weakness and pain.

Blocking the food pipe or airways - A tumor that grows in the airway of the lung or food pipe will block it. This will cause issues like shortness of breath, pneumonia, and difficulty in swallowing food. Cancers that develop near the food pipe can make a person feel pain when swallowing food.

"Some other lung cancer complications occur when the disease spreads to other organs in the body," says Dr. Godinez. "Good news is that treatments are available for all these complications. The treatment option will depend on your overall health, age, and the type of complication you have."

# data[].attributes.attachment_link.title
Dr. Godinez Lists Complications Experienced By Lung Cancer Patients

# data[].attributes.attachment_link.description
Decatur, TX - February 13, 2020 - When detected early, lung cancer can be treated. A patient should understand the symptoms in order to get diagnosed early. Lung cancer may cause complications to the lungs and other body parts, and the complications may occur over time as the disease develops and advances.

# data[].attributes.headline
Breast Cancer - Prevention, Detection and Treatment

# data[].attributes.subject
Breast Cancer - Prevention, Detection and Treatment

# data[].attributes.body
Cancer is a deadly disease that requires proactive measures to defeat. Regular screening and checkups can help identify the disease early while it’s treatable.

# data[].attributes.attachment_link.readable_text
Cancer is a deadly disease that requires proactive measures to defeat. Regular screening and checkups can help identify the disease early while it's treatable. Breast cancer incidence in women across the world is very high and is expected to rise in the coming years.

Mammography is the standard method for detecting breast cancer early. The procedure can identify tiny lesions in the breast before any symptoms manifest. Regular mammography tests increase the chances of successful treatments and survival of the patients.

It is important to know the preventive measures for breast cancer and how to detect and treat the disease. A mammography test is a short procedure that takes about 20 minutes. It is safe, with minimal discomfort to the patient.

Detecting breast cancer in its early stages can reduce one's risk of dying from the disease. It is recommended for women to start taking mammography tests every year from the age of 40 or early if their risks are higher. People at high risk of the disease are those with family and personal history of the disease.

People who don't take regular mammograms risk their cancer growing and spreading to other body parts.

However, not all breast cancers are detectable by mammography. Your doctor will recommend an annual clinical breast exam to help identify any changes in your breasts. You can also perform a breast self-exam at home to understand the normal appearance and feel of your breasts. Any abnormal change you may notice, such as a lump, should be reported to the doctor. Breast self-exams can be done alongside other screening tests.

Screening for breast cancer is essential. It can save your life by catching the disease early and treating it effectively. It is vital to invest in your health by taking the necessary preventive measures and getting examined and diagnosed for breast cancer early.

# data[].attributes.attachment_link.title
Ways for Prevention, Detection, and Treatment of Breast Cancer

# data[].attributes.attachment_link.description
Cancer is a deadly disease that requires proactive measures to defeat. Regular screening and checkups can help identify the disease early while it's treatable. Breast cancer incidence in women across the world is very high and is expected to rise in the coming years. Mammography is the standard method for detecting breast cancer early.

# data[].attributes.body
About 60% of all cases of colon cancer affect the intestines, while the remaining 40% is from the rectum.

# data[].attributes.attachment_link.readable_text
A patient's chance of recovering from colon cancer is relatively low. In its final stages, the chances of survival from colorectal cancer are very minimal and end in the death of the patient. But if identified early, survival rates can improve.

About 60% of all cases of colon cancer affect the intestines, while the remaining 40% is from the rectum. The cancers stem from malignant tumors that develop in the mucous membrane of the colon. They often do not cause symptoms.

Colorectal cancer mostly occurs in people aged 50 years and above. It is, therefore, vital to be very cautious at this age in order to identify its symptoms early enough and get treated. Screening is also crucial, especially if you experience symptoms such as:

Constipation

Increase in the abdominal volume

Persistent diarrhea

Frequent abdominal pain

The urge to visit the toilet

Blood in the stool

Vomiting

Colorectal cancer also presents symptoms that are barely noticeable such as unexplained weight loss and anemia.

Some other severe symptoms can occur when the disease has already progressed. The patient will experience conditions like peritoneum inflammation and intestinal obstruction.

Clinical exams such as rectal examination can help find any abnormalities in the colon and rectum and allow further tests to confirm whether they are cancerous or not. A special test called the Guaiac test or Haemoccult test can help identify tiny traces of blood and antibodies in the stool for further diagnosis.

Colonoscopy is the standard screening method for colorectal cancer. Sometimes a proctoscopy may also be conducted in the rectum to find the tumors and allow the patient to undergo biopsy. Further tests will be carried out to confirm the form, type, and stage of the cancer. This will help doctors to develop an appropriate treatment plan to rid the body of the tumor.

# data[].attributes.attachment_link.title
How to Recognize Colon Cancer - North Texas Center

# data[].attributes.attachment_link.description
A patient's chance of recovering from colon cancer is relatively low. In its final stages, the chances of survival from colorectal cancer are very minimal and end in the death of the patient. But if identified early, survival rates can improve.

# data[].attributes.headline
What its like Living with Prostate Cancer

# data[].attributes.subject
What its like Living with Prostate Cancer

# data[].attributes.body
Prostate cancer is often diagnosed in older men, and the majority of them do not die from the disease, but from other unrelated conditions such as stroke and heart disease.

# data[].attributes.attachment_link.readable_text
Prostate cancer is common in men. Of all cancer diagnoses, prostate cancer is often the less serious one. The disease is common with aging since it grows and spreads slowly. It has high survival rates compared to other types of cancers. Many men die not knowing prostate cancer was present.

Prostate cancer is often diagnosed in older men, and the majority of them do not die from the disease, but from other unrelated conditions such as stroke and heart disease.

Overall, the survival rates of prostate cancer are quite favorable. About 92% of cases are diagnosed in early stages (local), and almost all men with local disease will survive for more than five years after their diagnosis. A small percentage of men will be diagnosed with advanced prostate cancer.

Survival rates for prostate cancer reduce when the disease has already spread beyond the prostate. Men with metastatic prostate cancer have little chances of surviving for five years after their diagnosis.

Many prostate cancer patients can actually live longer than five years after diagnosis. The American Society of Clinical Oncology highlights that men with local or regional prostate cancer have a 10-year survival rate of 98% and a relative 15-year survival rate of 96%.

Prostate cancer is staged using the TNM system. The system helps to describe each patient's disease in detail, which allows doctors to decide on treatment.

Living with prostate cancer means having to choose the best treatment options, and coping with the side effects, such as fatigue, incontinence, and erectile dysfunction. It also means dealing with the life changes and emotions that come after diagnosis.

Consulting with the urologist can help you understand the potential side effects to expect during treatment. Together, you can develop a good plan to deal with the side effects as they come.

While most patients respond well to prostate cancer treatment and the rates of survival are promising, it is important to know that treatments can change you emotionally and physically. Some of the side effects are persistent and will remain with you even after you complete your treatment. Your doctor can help you improve your life after surviving treatment.

# data[].attributes.attachment_link.title
Living with Prostate Cancer | Cancer Center at Wise Regional

# data[].attributes.attachment_link.description
Prostate cancer is common in men. Of all cancer diagnoses, prostate cancer is often the less serious one. The disease is common with aging since it grows and spreads slowly. It has high survival rates compared to other types of cancers. Many men die not knowing prostate cancer was present.

# data[].attributes.headline
What are the early symptoms of lung cancer?

# data[].attributes.subject
What are the early symptoms of lung cancer?

# data[].attributes.body
Lung cancer leads the chart as a leading cause of cancer deaths across the world. The disease often develops in people who smoke.

# data[].attributes.attachment_link.readable_text
Lung cancer leads the chart as a leading cause of cancer deaths across the world. The disease often develops in people who smoke. Most patients with the disease do not experience any symptoms until later when it has spread to other body parts.

Some early symptoms for lung cancer may come from other health conditions like smoking and other factors. They include;

Back, shoulder, or chest pain- Lungs have few nerve endings, and that is why patients with lung cancer don't feel any early-stage symptoms.

When the disease has metastasized to areas like the vertebrae, chest wall, ribs, and some nerves, that is when the patient will feel some pain. Pancoast tumors that form at the top of the lungs cause shoulder pain since they invade surrounding tissues.

As the tumor grows, the patient will feel pain in the chest, arms, back, and a hoarse voice as well. This is because the tumor begins to press on the laryngeal nerve, paralyzing the vocal code.

Unexplained weight loss - Sudden weight loss can be a sign of the presence of lung cancer. Weight loss from cancer can be due to changes to the body's hormones, immune function, and metabolism, shortness of breath and wheezing, loss of appetite, and difficulty in swallowing food.

Persistent cough - A cough that doesn't go away can be a sign of lung cancer in its early stages. The cough may also produce blood. Regularly coughing can also indicate a different lung condition.

Fatigue - Lung cancer can cause a reduction in red blood cells, making you anemic. The red blood cells are responsible for transporting oxygen to the body, and being anemic can cause severe fatigue, tiredness, and difficulty in carrying out everyday activities.

If you experience such symptoms, you should visit the doctor immediately to confirm whether it is lung cancer or some other condition.

# data[].attributes.attachment_link.title
Early Symptoms of Lung Cancer - North Texas Center

# data[].attributes.attachment_link.description
Lung cancer leads the chart as a leading cause of cancer deaths across the world. The disease often develops in people who smoke. Most patients with the disease do not experience any symptoms until later when it has spread to other body parts.

# data[].attributes.headline
Metastatic Breast Cancer and Hormonal Therapy

# data[].attributes.subject
Metastatic Breast Cancer and Hormonal Therapy

# data[].attributes.body
Treatment for metastatic breast cancer is administered to ensure a patient can survive longer with the disease, experiences fewer side effects, and enjoys a quality life. Currently, there is no possible cure for metastatic breast cancer.

# data[].attributes.attachment_link.readable_text
Decatur, TX - January 17, 2020 - Treatment for metastatic breast cancer is administered to ensure a patient can survive longer with the disease, experiences fewer side effects, and enjoys a quality life. Currently, there is no possible cure for metastatic breast cancer. Treatments given depend on several factors such as the gene mutations in the tumor, levels of HER2 and/or hormone receptors, and other organs that the cancer has spread to, and more.

"Oncologists often work together in a multidisciplinary system to develop appropriate treatment plans for patients," explained Dr. Echt. "Treatment options for metastatic breast cancer vary. Some, like hormonal therapy, is ideal for hormone receptor-positive breast cancers."

Here are the various options for hormonal therapy for breast cancer:

Aromatase inhibitors (AIs) - Aromatase inhibitors can reduce the amount of oxygen produced by tissue by blocking the aromatase enzyme. The enzyme changes androgens into estrogen. Aromatase inhibitors include letrozole, exemestane, and anastrozole (Arimidex).

Tamoxifen (Soltamox) - This is a drug that prevents estrogen for binding to the breast cancer cells. It is an oral drug used on all breast cancer patients. It helps to improve cholesterol levels and bone health.

Ovarian suppression - This can be used together with tamoxifen, AI, or fulvestrant to cause temporary menopause by stopping ovaries from making estrogen. They include leuprolide or goserelin. Surgery can also stop estrogen production permanently. Ovarian suppression treats hormone receptor-positive metastatic breast cancers in younger women.

Fulvestrant (Faslodex) - This is a selective estrogen receptor downregulator (SERD) that helps to prevent the ability of estrogen attaching to estrogen receptors. It is used only in women of menopausal age.

"Hormonal therapy helps to reduce the levels of progesterone and estrogen in the body to block them from reaching cancer cells," continued Dr. Echt. "This will prevent cancer cells from using the hormones to grow and multiply. Hormone therapy can be combined with other targeted therapies to treat metastatic breast cancer. "However, it cannot be used with chemotherapy.

# data[].attributes.attachment_link.title
Understanding Hormonal Therapy for Metastatic Breast Cancer

# data[].attributes.attachment_link.description
Decatur, TX - January 17, 2020 - Treatment for metastatic breast cancer is administered to ensure a patient can survive longer with the disease, experiences fewer side effects, and enjoys a quality life. Currently, there is no possible cure for metastatic breast cancer.

# data[].attributes.headline
Artificial Intelligence and Lung cancer Immunotherapy

# data[].attributes.subject
Artificial Intelligence and Lung cancer Immunotherapy

# data[].attributes.body
Immunotherapy is a cancer treatment that enhances the body’s immune response to fight cancer tumors. Scientists have developed an artificial intelligence (AI) model to help healthcare professionals identify lung cancer patients who can benefit from immunotherapy.

# data[].attributes.attachment_link.readable_text
Lung cancer is often aggressive, making it difficult to detect while in the early stages. It does not present any noticeable symptoms, either. Targeted therapy is the best option that will ensure positive outcomes for patients with this disease. However, before administering immunotherapy, doctors need to determine which patients can benefit from this option.

For favorable outcomes for lung cancer patients, physicians have to tailor treatment for each patient. This can be tricky, especially if they don't know who will benefit from a particular treatment. It may also be difficult for oncologists to determine how newer treatment options like immunotherapy will benefit an individual.

Immunotherapy is a cancer treatment that enhances the body's immune response to fight cancer tumors. Scientists have developed an artificial intelligence (AI) model to help healthcare professionals identify lung cancer patients who can benefit from immunotherapy.

According to their findings;

The new model can help both doctors and patients decide on the best therapy for their type of lung cancer. This will also minimize unnecessary expenses incurred during immunotherapy.

It was developed from other findings that succeeded in identifying the signs that spotted cancerous tumors that responded to treatment.

They discovered that textural change could effectively predict if treatment is working.

The research team used data from CT scans from patients an set up a mathematical method that helped to identify the texture and other changes in the size of the tumor. They then exposed them to two or three cycles of immunotherapy.

They identified patterns in patients that indicated that specific changes in tumors were connected to a positive response to immunotherapy with high survival rates.

Previous studies had suggested that tumor size could conclusively indicate whether or not a treatment approach was working in a patient. But this may not be accurate since a nodule can increase in size after therapy due to a different reason such as a broken vessel within the tumor. The new artificial intelligence model has accurately shown that lung tumors with noticeable changes in their texture can respond to immunotherapy with the best patient outcomes.

# data[].attributes.attachment_link.title
Artificial Intelligence and Who Benefits from Lung Cancer Immunotherapy

# data[].attributes.attachment_link.description
Lung cancer is often aggressive, making it difficult to detect while in the early stages. It does not present any noticeable symptoms, either. Targeted therapy is the best option that will ensure positive outcomes for patients with this disease. However, before administering immunotherapy, doctors need to determine which patients can benefit from this option.

# data[].attributes.headline
Understanding Comprehensive Cancer Care in Simple Terms

# data[].attributes.subject
Understanding Comprehensive Cancer Care in Simple Terms

# data[].attributes.body
According to the National Comprehensive Cancer Network, many cancer survivors have difficulty understanding terminologies related to their disease.

# data[].attributes.attachment_link.readable_text
According to the National Comprehensive Cancer Network, many cancer survivors have difficulty understanding terminologies related to their disease. Most patients are left hanging when clinicians use esoteric language while treating them. Since their main concern is their health, they need to have a mutual patient-physician relationship by understanding and participating in their treatment process. Speaking the same language will help them cope better.

Many targeted treatment options for cancer have emerged so far. For patients to make informed decisions regarding their care, they need to be able to understand the oncology lexicon better. Although clinicians may try to communicate options to patients in a more comprehensible manner, the cancer language can remain puzzling for some, especially when it comes to clinical trials.

To help patients understand their care better;

The healthcare team, including oncologists, pharmacists, nurses, and patient advocacy groups have been called to develop a language that is patient-friendly. This will help to efficiently communicate treatment and results during clinical trials.

To increase patient understanding and participation, a set of oncology definitions can be developed for the drugs used in clinical trials. Involving patients in their care procedures can help to produce fruitful results and the overall increase in their response rates.

Complex terminologies for cancer diagnosis and treatment leave patients wondering where to get the information and resources they need to understand their care. The FDA has confirmed from public workshops how patients face difficulty when trying to understand trial terminologies such as OS, PFS, DFS, and more that convey the harms and benefits of their treatment.

Such terms are only useful to cancer drug researchers and clinicians, but not for patients who need to decide about their care in clinical trials. Because of the overwhelming time pressures in the clinic, providing easily understandable terminologies to patients will create a comfortable environment for patients to choose the right care.

# data[].attributes.attachment_link.title
Patients Understand Comprehensive Cancer Care in Simple Terms

# data[].attributes.attachment_link.description
According to the National Comprehensive Cancer Network, many cancer survivors have difficulty understanding terminologies related to their disease. Most patients are left hanging when clinicians use esoteric language while treating them. Since their main concern is their health, they need to have a mutual patient-physician relationship by understanding and participating in their treatment process.

# data[].attributes.body
A study has observed that many young people born in the 1990s are developing colorectal cancer at alarming rates. Furthermore, millennials are likely to develop the disease twice as much compared to the young adults born in the 1950s.

# data[].attributes.attachment_link.readable_text
A study has observed that many young people born in the 1990s are developing colorectal cancer at alarming rates. Furthermore, millennials are likely to develop the disease twice as much compared to the young adults born in the 1950s. As for older generations, it was found that colorectal cancer incidents have dropped tremendously.

The Center for Disease Control and Prevention recommendations state that people to start screening for colorectal cancer at age 50. But with the new developments, this could change soon. What could really be the reason behind the increasing risks in millennials? Some oncologists attribute it to the rising cultural and lifestyle shifts that have taken place during the last century.

Before, people had an active and healthy lifestyle. A diet full of freshly prepared foods from the farm. Today there is less activity and a more health-threatening sedentary lifestyle that leads to obesity in the younger generation. The rates of obesity keep increasing in Black and Latin Americans each day, according to a report.

Generally, obesity, sedentary lifestyles, and smoking are the main causal factors for colon cancer. People with a history of colorectal cancer are also at high risk. In young adults, the disease is often diagnosed at a late stage, probably due to ignorance and perception that colon cancer develops in older adults. This leads to late screening and diagnosis, making treatment harder for the patients.

The symptoms for colorectal cancer include unexplained weight loss, dark-colored stool, abdominal bloating, vomiting, among others. Most symptoms can be overlooked and lead to late diagnosis. However, colorectal cancer is highly treatable, especially when caught early and still localized.

Screening for colorectal cancer is the only way to identify it early and ensure successful treatment. Many young adults avoid screening procedures like colonoscopy because of the discomfort involved in the procedure. But there are other screening methods such as flexible sigmoidoscopy and fecal occult blood tests.

The rise in colorectal cancer risks in young adults calls for a widespread campaign to create awareness to the public. They need to be sensitized to practice healthy habits such as exercising, healthy diets, limiting smoking and alcohol consumption, and much more.

# data[].attributes.attachment_link.title
Why the Risk of Colorectal Cancer is High among Millennials

# data[].attributes.attachment_link.description
A study has observed that many young people born in the 1990s are developing colorectal cancer at alarming rates. Furthermore, millennials are likely to develop the disease twice as much compared to the young adults born in the 1950s. As for older generations, it was found that colorectal cancer incidents have dropped tremendously.

# data[].attributes.body
Studies indicate that a diet high in fats can increase the risks of the disease. Scientists have found a connection in the way body cells consume fate and how genes regulate the behavior of stem cells in intestines.

# data[].attributes.attachment_link.readable_text
Colorectal cancer is widespread in people across the world. The colon is an organ that plays a significant role in the body's digestive system. It helps to process and supply nutrients to the body. Colorectal cancer symptoms may go unnoticed in early stages; that is why it is recommended for people to start screening at the age of 50 or 40 for those at high risk.

A lot of people are at high risk of developing colorectal cancer due to dietary and other factors. Incidences of the disease are high in some parts of the world and low in others. People who are obese, smokers, elderly are of African descent, and have a family history or consume high amounts of alcohol are prone to colorectal cancer risks.

Studies indicate that a diet high in fats can increase the risks of the disease. Scientists have found a connection in the way body cells consume fate and how genes regulate the behavior of stem cells in intestines.

According to a study;

The two genes that help stem cells to burn fats in the body have a role in colon cancer risk. They include the HNF4A and HNF4G genes, which work to ensure that the intestinal lining is functioning correctly.

Too much fat in the intestines can increase the number of stem cells and boost an individual's risk of colon cancer.

The stem cells in the intestines get renewed constantly to help fuel the regeneration of the intestinal lining. Any alteration in the function of the stem cells can cause colon cancer.

When the genes are inactivated, the intestinal stem cells are likely to malfunction, causing the intestines to stop burning fat.

In conclusion, it was observed that the two genes could help the stem cells to burn fat and generate energy as well. However, more studies are required in order to determine if these genes can alter the cancer risk and the stem cell numbers when one consumes a high-fat diet.

# data[].attributes.attachment_link.title
High Fat Diet May Elevate Colon Cancer Risks

# data[].attributes.attachment_link.description
Colorectal cancer is widespread in people across the world. The colon is an organ that plays a significant role in the body's digestive system. It helps to process and supply nutrients to the body. Colorectal cancer symptoms may go unnoticed in early stages; that is why it is recommended for people to start screening at the age of 50 or 40 for those at high risk.